HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Akalin, H. Articles by Erol, C. Search for Related Content PubMed PubMed Citation Articles by Akalin, H. Articles by Erol, C.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 259-266, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Clinical evaluation of the Omniscience cardiac valve prosthesis. Follow- up of up to 6 years

H Akalin, ET Corapcioglu, U Ozyurda, K Ucanok, A Uysalel, B Kaya, NT Eren and C Erol
Department of Cardiovascular Surgery, Ankara University, Ibn-i Sina Hospital, Turkey.

From January 1984 to June 1989, 259 Omniscience valve prostheses were implanted in 225 patients. Of the 225 patients; 143 (63.6%) received mitral, 48 (21.3%) aortic, and 34 (15.1%) double valve replacements. The early mortality rate was 8.9%; 97.6% of the patients were included in this study. These patients represent a cumulative follow-up of 407.9 patient-years, with a mean follow-up of 2.03 +/- 0.1 (standard error) years. The late mortality rate was 4.03% overall, which corresponds to 2.0% +/- 0.7%/pt-yr (SE). The annual rate of valve endocarditis was 1.0% +/- 0.5%/pt-yr (SE). The linearized rate of thromboembolism was 1.2% +/- 0.5%/pt-yr (SE). Anticoagulant-related hemorrhage occurred in 15 patients with an annual rate of 3.7% +/- 0.9%/pt-yr (SE). The linearized rate of valve thrombosis was 0.2% +/- 0.2%/pt-yr (SE). By echocardiography the mean mitral valve opening was 75.9 +/- 3.1 degrees (standard deviation) for 27 patients. During follow-up study, 136 (70.8%) patients were in New York Heart Association class I, 44 (22.9%) were in class II, and 12 (6.3%) were in class III; there were 25 (11.1%) patients in class II, 166 (73.8%) in class III, and 34 (15.1%) in class IV preoperatively. Actuarial freedom from thromboembolism was 94.5% +/- 3.6% (SE); freedom from endocarditis, 97.8% +/- 1.0% (SE); freedom from anticoagulant-related hemorrhage, 91.5% +/- 2.0% (SE); freedom from valve thrombosis 99.1% +/- 0.8% (SE); and freedom from hemolysis 98.5% +/- 1.2% (SE). Actuarial survival at 6 years is 94.0% + 2.3% (SE) overall. In conclusion, the overall rate of valve-related complications with this valve is low.

This article has been cited by other articles:

				T. Gudbjartsson, T. Absi, and S. Aranki Mitral Valve Replacement Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068. [Full Text]

				U. Ozyurda, A. R. Akar, O. Uymaz, M. Oguz, M. Ozkan, C. Yildirim, A. Aslan, and R. Tasoz Early clinical experience with the On-X prosthetic heart valve Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 588 - 594. [Abstract] [Full Text] [PDF]

				T. Gudbjartsson, S. Aranki, and L. H. Cohn Mechanical/Bioprosthetic Mitral Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986. [Full Text]

				M. S. Edwards, G. B. Russell, A. F. Edwards, J. W. Hammon Jr, A. R. Cordell, and N. D. Kon Results of valve replacement with omniscience mechanical prostheses Ann. Thorac. Surg., September 1, 2002; 74(3): 665 - 670. [Abstract] [Full Text] [PDF]

				S. K. Choudhary, A. Mathur, P. Venugopal, B. Airan, R. Sharma, A. Bhan, A. Saxena, A. Sampath Kumar, S. K. Choudhary, A. Mathur, et al. Prosthesis Size in Aortic Valve Replacement: Surgeon-Related Variable Asian Cardiovasc Thorac Ann, December 1, 2000; 8(4): 333 - 338. [Abstract] [Full Text] [PDF]

				M. J.R. Dalrymple-Hay, R. Pearce, S. Dawkins, M. P. Haw, R. K. Lamb, S. A. Livesey, and J. L. Monro A single-center experience with 1,378 CarboMedics mechanical valve implants Ann. Thorac. Surg., February 1, 2000; 69(2): 457 - 463. [Abstract] [Full Text] [PDF]

				C. W. Akins Results With Mechanical Cardiac Valvular Prostheses Ann. Thorac. Surg., December 1, 1995; 60(6): 1836 - 1844. [Abstract] [Full Text]

				A. E. Fiane, K. Saatvedt, J. L. Svennevig, O. Geiran, K. Nordstrand, and T. Froysaker The CarboMedics Valve: Midterm Follow-up With Analysis of Risk Factors Ann. Thorac. Surg., October 1, 1995; 60(4): 1053 - 1058. [Abstract] [Full Text]

				C. W. Akins Clinical evaluation of the Omniscience cardiac valve prosthesis (J THORAC CARDIOVASC SURG 1992;103:259-66) J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 631 - 631. [Full Text]